Cromwell Holdings’s Edwards Lifesciences EW Stock Holding History

Cromwell Holdings’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$190K	Buy	2,099 +194	+10%	+$16.3K	0.09%	221
2026 Q1	$153K	Hold	1,905	–	–	0.09%	233
2025 Q4	$162K	Sell	1,905 -58	-3%	-$4.76K	0.09%	214
2025 Q3	$153K	Hold	1,963	–	–	0.08%	238
2025 Q2	$154K	Sell	1,963 -13	-0.7%	-$970	0.09%	219
2025 Q1	$143K	Sell	1,976 -2	-0.1%	-$143	0.09%	221
2024 Q4	$146K	Buy	+1,978	New	+$138K	0.08%	216
2024 Q3	–	Sell	-1,933	Closed	-$179K	–	619
2024 Q2	$179K	Buy	+1,933	New	+$171K	0.11%	168

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Cromwell Holdings's EW Position: Q2 2026 in Review

Cromwell Holdings increased its Edwards Lifesciences (EW) stake by 10% in Q2 2026, buying an estimated $16.3K and bringing the position to 2,099 shares worth $190K. The position accounts for 0.09% of the portfolio, ranked #221.

Cromwell Holdings first reported a position in EW in Q2 2024 and has held it in 8 quarters since. 301 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Cromwell Holdings held 2,099 shares of Edwards Lifesciences worth $190K as of Q2 2026.
Cromwell Holdings bought 194 Edwards Lifesciences shares in Q2 2026, an estimated $16.3K.
Edwards Lifesciences made up 0.09% of Cromwell Holdings's portfolio in Q2 2026, its #221 holding.
Cromwell Holdings first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 8 quarters since.
301 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.